Jim Cramer and Bob Lang Talk Biotechs on Mad Money/Off the Charts
by Elisabeth Gurdus. As Wall Street froths at the prospect of Washington officials cracking down on drug pricing, Jim Cramer took to the charts to sift some promising biotech winners from the noise. “Sometimes it makes sense to fear what’s going on in Washington, but sometimes political worries are simply a smokescreen that the shorts…
Details